[Antiarrhythmic effect of beta-N-hexamethyleneimino-para-butoxypropiophenone (TG-17), novocainamide and quinidine in cardiac arrhythmias evoked by strophanthin K in cats].
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D002415:Cats; D004562:Electrocardiography; D005260:Female; D006323:Heart Arrest / Q000139:chemically induced; D006352:Heart Ventricles / Q000187:drug effects; D008297:Male; D011342:Procainamide / Q000009:adverse effects / Q000627:therapeutic use*; D011427:Propiophenones / Q000627:therapeutic use*; D011802:Quinidine / Q000009:adverse effects / Q000627:therapeutic use*; D013268:Stimulation, Chemical; D013328:Strophanthins / Q000494:pharmacology*; D013610:Tachycardia / Q000139:chemically induced; D014693:Ventricular Fibrillation / Q000139:chemically induced
D000889:Anti-Arrhythmia Agents; D011427:Propiophenones; D013328:Strophanthins; D011802:Quinidine; D011342:Procainamide
Antiaritamicheskaia aktivnost' beta-N-geksametilenimino-para-butoksipropiofenona (TG-17), novokainamide i khinidina pri aritmiiakh serdtsa, vyzvannykh strofantinom k u koshek.